What the business is, and whether it's a good one at a fair price.
Sells solar PV modules to private domestic buyers and operates a 5 MW solar project in Jakasana, Gujarat. The company, formerly pharmaceutical-focused, is pivoting to renewable energy and has proposed renaming itself Regenova Renewtech Limited. FY26 revenue was Rs. 36.32 crore, up 91% year-on-year, with new solar activity reported at 77% of revenue. Solar PV module orders booked during FY26 include about Rs. 14.49 crore from Deon Energy for 16,129 modules of 620 WP, Rs. 3.49 crore from Earthwave Technology for 4,056 modules, Rs. 3.11 crore from Earthwave Technology for 3,645 modules, Rs. 1.21 crore from Perfect Renewtech for 1,355 modules, and Rs. 1.07 crore from Ottrive Lifestyle for 1,334 modules of 600 WP. Q1 FY27 revenue rose 414% year-on-year to Rs. 12.45 crore. The business operates as a single reportable segment with very low employee and other operating costs (Rs. 0.18 crore and Rs. 0.21 crore respectively in FY26) and heavy capex of Rs. 20.76 crore (57.2% of revenue) tied to the renewable-energy shift.
Measured from the filed financials, judged against its Pharmaceuticals peers · as of FY26 — not investment advice
How has the market priced it — with filings on the timeline?
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
How does it stack up on valuation, returns and growth?
Loading peers…
Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.
Loading financials…
Who owns it — and is the promoter stake clean?
Loading shareholding…
Sign up to see the full company file
Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.
Answered from GUJARAT INJECT (KERALA) LTD.'s filed financials and exchange disclosures
GUJARAT INJECT (KERALA) LTD. is a Pharmaceuticals & Biotechnology company listed on BSE.
Yes. Over the trailing twelve months GUJARAT INJECT (KERALA) LTD. reported a net profit of ₹2 Cr on revenue of ₹36 Cr.
Not in the latest reported year — GUJARAT INJECT (KERALA) LTD.'s dividend payout for FY26 was nil.
Effectively yes. It holds ₹1 Cr more cash than debt. Debt stands at 0.00× equity.
On trailing P/E, GUJARAT INJECT (KERALA) LTD. ranks 7 of 169 in Pharmaceuticals — cheaper than 95% of them, against an industry median of 28.9×. This is a position, not a valuation judgement.
Every NSE and BSE filing by GUJARAT INJECT (KERALA) LTD. appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.
Figures are as last reported and may lag the latest filing. Not investment advice.
